Availability of multi-omic data (DNA, RNA, protein, PTM, metabolite) types per patient
Individuals with chronic obstructive pulmonary disease (COPD) experience long-term oxidative damage and lung tissue inflammation, leading to blocked airways, shortness of breath, and coughing
Helping with weight loss Some GLP-1 agonists are specifically manufactured and FDA-approved and prescribed for weight loss
This translates to approximately 70+ pounds for someone starting at 250 pounds
Loss of muscle can be detrimental to metabolism and aging, affecting strength, mobility, decreasing metabolic rate, increasing risk of insulin resistance, diabetes, cardiovascular health, and overall quality of life
Nitrotyrosine was postulated to be mediated by peroxynitrite, a reactive nitrogen species formed by the very rapid reaction of superoxide and nitric oxide (NO)